0.00(0.00%)

+105.729(+0.39%)

+53.26(+0.26%)

These top 10 stocks can return up to 55% in 1 year

Podcast | Stock Picks of the Day: 3 buys that could return 7-8%

The index is currently trading above its 20, 50, 100 and 200-day daily moving average, indicating a bullish trend on all time frames. It has been forming higher tops and bottoms on the daily charts, confirming a bullish set up.

Moneycontrol News

After a recent run-up, the market has been consolidating as investors digest outcome of the Karnataka election. It has started monitoring corporate earnings and the movement of the rupee and crude oil prices.

The rupee stabilised after hitting a fresh 16-month low of 68.15 against the dollar while the crude oil prices inched towards the $80 per barrel.

Analysts feel India, which imports more than 80 percent of its oil requirements, can manage to absorb up to $80 per barrel but beyond that it could be a major risk. “Along with geopolitical tensions, crude, rupee-dollar and rising US bond yields are some major risk to India.”

However, they are betting on an earnings recovery in FY19.

Nomura too is betting on an earnings recovery to take markets higher.

The global investment bank sees Nifty hitting fresh record highs in 2018. It expects the index to surpass its earlier record high of 11,171 recorded in January. “We see the Nifty scaling levels of around 11,380 by December,” it said in a strategy note.

Here is the list of 10 stocks that can return up to 55 percent over the next 12 months:

Lupin's US business performance was encouraging as revenues grew 5 percent QoQ to USD 224 million in Q4FY18. It was largely led by new product approvals during last two quarters and strong flu season. Although gSynthroid approval has been delayed to second half of FY19, we expect Lupin's US revenues to grow at least in mid-single digit in FY19, along with strong double digit growth in emerging market segments (including India).

With moderated R&D spend (10 percent of sales) and lucrative opportunities like gRanexa and gSythroid, we expect Lupin to largely maintain EBITDA margin in FY19. Lending strong support from valuations (20x P/E on FY18 EPS, 19x FY19E and 13x FY20E) which is at significant discount to peers, we maintain Buy rating on the stock with a target price of Rs 1,190 (20x FY20E).

Brokerage: Prabhudas Lilladher

RPP Infra Projects: Buy | Target - Rs 379 | Return - 50%

RPP reported strong result in Q4FY18 led by better execution and improved margins. The company achieved its guidance of Rs5bn sales and Rs 1,200 crore order book for FY18. It is guiding for Rs 700 crore sales and Rs 1,600 crore order book for FY19.

Positives also included improvement in working capital by 26 days led by significant reduction in debtor’s days. It further expects to reduce working capital by 10-15 days in FY19.

We believe the company is a good play on government’s increasing focus on improving rural infrastructure. We expect RPP to deliver sales and PAT CAGR of 31/35 percent, respectively, over FY17-20E. We maintain Buy at a target price of Rs 379.

Brokerage: ICICI Securities

Magma Fincorp: Buy | Target - Rs 230 | Return - 26%

Magma Fincorp was trading at subdued valuations due to its slippages from FY14 and peaking in FY16. The stock is currently trading close to 1.9x trailing book value and 1.5x FY20E book value. Considering the strong retail portfolio with 60-65 percent book classified for PSL category offering securitisation benefits, these valuations look reasonable.

We believe that for return on equity of 11-12 percent and return on assets of more than 2 percent by FY20, the stock can trade at 2.3x FY20 P/ABV. Exposure to general insurance business through Magma HDI remains an added positive.

Factoring in the new focused management and improving margins and return ratios we value Magma at Rs 230 per share, i.e. 2.3x ABV and 16x P/E on an FY20E basis. We have a Buy recommendation from a 12-15 month’s perspective.

Magma Fincorp was incorporated in 1988 and began by offering vehicle and equipment financing solutions to individuals and small businesses in India. It later included commercial vehicle, tractor finance, SME loans as well as insurance.

Going ahead, we are upbeat on the company’s hunger for growth led by: 1) capacity addition of 6.7mt via INR444bn capex commitment through to FY21E; 2) USD 500 million investment in a US pipe & plate mill through to FY21E; 3) acquisition of 3mtpa Acero Junction Holdings in the US; and 4) potential acquisition of Lucchini Rail mill in Italy.

ACC, a leading brand with pan India presence (8 percent market share), is set to benefit from the expected rise in industry clinker utilisation. While ramp up of its new Jamul unit led to 14 percent volume growth in CY17 (fastest in past six years), in the absence of fresh capacity addition, volume growth is expected to moderate to around 5 percent CAGR over CY18-19.

However, on upcoming cement price hikes (mirroring rise in industry clinker utilisations), EBITDA is estimated to increase at 16 percent CAGR over the mentioned period. With plans to merge ACC with parent company, Ambuja Cement (ACEM) shelved, both companies have agreed to enter into a master supply agreement (MSA) to trade goods and services.

While initial synergy benefit estimates (around 3-5 percent of PBT) appear insipid, calling off the merger will see both players pursuing expansions independently – a medium to long term positive. Factoring in strong balance sheet (around Rs 2,600 crore net cash) and return on equity (RoE) improvement, we value ACC at 12x CY19E EV/EBITDA. Maintain Buy with a target price of Rs 1,817.

Calibrating for FY18 performance, recent trends in cement prices and fuel costs, while we prune FY19E EBITDA by 6 percent, we keep it largely unchanged for FY20E. Maintain Buy with target price of Rs 1,209.

Shree Cement: Buy | Target - Rs 20,544 | Return - 25%

Shree Cement (SRCM) is an investors' delight given positives like: 1) continuous gain in market share; 2) sharp focus on cost driving margins superior to peers; and 3) sustainable high RoEs (more than 17 percent). SRCM will also benefit from ~70% capacity exposure to North region where industry clinker utilisations are turning lucrative.

SRCM recently announced an acquisition of UAE-based Union Cement Company (UCC) at enterprise value (EV) of USD 305 million (EV/t of USD 76). Given strong balance sheet (net cash of around Rs 2,900 crore in FY17) and robust cash flows, there could be concerns of future global acquisitions.

However, these are overplayed as: a) management is focused to generate RoEs (for acquired companies) at least at par with the investment yield; and b) there’s no compromise on capex for targeted volume growth in India.

With multiple positives, we value SRCM’s robust India business at 16x FY20E EV/EBITDA and UCC at 8x. Maintain Buy with target price of Rs 20,544.

Muthoot’s other businesses—home finance, Belstar, insurance broking—scaling up well (10 percent of AUM). Given stability in the business along with RoA/RoE profile of more than 5/20 percent, we maintain Buy.

Going ahead, we envisage the performance to improve as: 1) Kalinganagar (KPO) is back on track post an unscheduled shutdown in February; 2) Tata Steel Europe’s (TSE) downstream units are back on track; and 3) stable spreads in domestic & overseas operations.

In the medium term, we see following drivers: a) value realisation from the Bhushan Steel transaction; and b) definitive agreement with ThyssenKrupp (TK) on JV for European assets. Maintain Buy with target price of Rs 903, implying an exit multiple of 7.0x FY20E EBITDA.

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.